{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:05:08Z","timestamp":1791119108486,"version":"4.1.0"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            An anthrax spore aerosol infection mouse model was developed as a first test of in vivo efficacy of antibiotics identified as active against\n            <jats:italic>Bacillus anthracis<\/jats:italic>\n            . Whole-body, 50% lethal dose (LD\n            <jats:sub>50<\/jats:sub>\n            ) aerosol challenge doses in a range of 1.9 \u00d7 10\n            <jats:sup>3<\/jats:sup>\n            to 3.4 \u00d7 10\n            <jats:sup>4<\/jats:sup>\n            CFU with spores of the fully virulent Ames strain were established for three inbred and one outbred mouse strain (A\/J, BALB\/c, C57BL, and Swiss Webster). The BALB\/c strain was further developed as a model for antibiotic efficacy. Time course microbiological examinations of tissue burdens in mice after challenge showed that spores could remain dormant in the lungs while vegetative cells disseminated to the mediastinal lymph nodes and then to the spleen, accompanied by bacteremia. For antibiotic efficacy studies, BALB\/c mice were challenged with 50 to 100 LD\n            <jats:sub>50<\/jats:sub>\n            of spores followed by intraperitoneal injection of either ciprofloxacin at 30 mg\/kg of body weight (every 12 h [q12h]) or doxycycline at 40 mg\/kg (q6h). A control group was treated with phosphate-buffered saline (PBS) q6h. Treatment was begun 24 h after challenge with groups of 10 mice for 14 or 21 days. The PBS-treated control mice all succumbed (10\/10) to inhalation anthrax infection within 72 h. Sixty-day survival rates for ciprofloxacin and doxycycline-treated groups were 8\/10 and 9\/10, respectively, for 14-day treatment and 10\/10 and 7\/10 for 21-day treatment. Delayed treatment with ciprofloxacin initiated 36 and 48 h postexposure resulted in 80% survival and was statistically no different than early (24 h) postexposure treatment. Results using this mouse model correlate closely with clinical observations of inhalational anthrax in humans and with earlier antibiotic studies in the nonhuman primate inhalational anthrax model.\n          <\/jats:p>","DOI":"10.1128\/aac.01050-06","type":"journal-article","created":{"date-parts":[[2007,2,13]],"date-time":"2007-02-13T01:18:31Z","timestamp":1171329511000},"page":"1373-1379","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":72,"title":["Determination of Antibiotic Efficacy against\n            <i>Bacillus anthracis<\/i>\n            in a Mouse Aerosol Challenge Model"],"prefix":"10.1128","volume":"51","author":[{"given":"Henry S.","family":"Heine","sequence":"first","affiliation":[{"name":"Division of Bacteriology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bassett","sequence":"additional","affiliation":[{"name":"Division of Bacteriology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Bacteriology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Hartings","sequence":"additional","affiliation":[{"name":"Division of Aerobiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Ivins","sequence":"additional","affiliation":[{"name":"Division of Bacteriology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Louise","family":"Pitt","sequence":"additional","affiliation":[{"name":"Division of Aerobiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fritz","sequence":"additional","affiliation":[{"name":"Division of Bacteriology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Norris","sequence":"additional","affiliation":[{"name":"Biostatistical Services, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Russell","family":"Byrne","sequence":"additional","affiliation":[{"name":"Division of Bacteriology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.6.2291"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.11.6231-6241.2002"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0906.030118"},{"key":"e_1_3_2_5_2","first-page":"306","volume":"340","year":"1992","unstructured":"Bradaric, N., and V. Punda-Polic. 1992. Cutaneous anthrax due to penicillin-resistant Bacillus anthracis transmitted by an insect bite. Lancet340:306-307.","journal-title":"Lancet"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00464-2"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068474"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.2.661-664.2002"},{"key":"e_1_3_2_9_2","first-page":"889","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Update: investigation of anthrax associated with intentional exposure and interim public health guidelines. Morb. Mortal. Wkly. Rep.50:889-897.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_10_2","first-page":"909","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy. Morb. Mortal. Wkly. Rep.50:909-919.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.12.4873-4877.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1766-1766.2000"},{"key":"e_1_3_2_13_2","first-page":"1","year":"2002","unstructured":"Craig, W. A. 2002. Pharmacodynamics of antimicrobials: general concepts and applications, p. 1-22. In C. H. Nightingale, T. Murakawa, and P. G. Ambrose (ed.), Antimicrobial pharmacodynamics in theory and clinical practice. Marcel Dekker, Inc., New York, NY.","journal-title":"Antimicrobial pharmacodynamics in theory and clinical practice"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.5099-5106.2005"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549109024319"},{"key":"e_1_3_2_16_2","first-page":"382","year":"1986","unstructured":"Edberg, S. C. 1986. The measurement of antibiotics in human body fluids: techniques and significance, p. 382-399. In V. Lorian (ed.), Antibiotics in laboratory medicine, 2nd ed. Williams and Wilkins, Baltimore, MD.","journal-title":"Antibiotics in laboratory medicine"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.11.3463-3471.2002"},{"key":"e_1_3_2_18_2","first-page":"37988","volume":"67","year":"2002","unstructured":"Federal Register. 2002. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Fed. Regist.67:37988-37998.","journal-title":"Fed. Regist."},{"key":"e_1_3_2_19_2","first-page":"335","volume":"20","year":"2000","unstructured":"Friedlander, A. M. 2000. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Curr. Clin. Top. Infect. Dis.20:335.","journal-title":"Curr. Clin. Top. Infect. Dis."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.5.1239"},{"key":"e_1_3_2_21_2","first-page":"691","volume":"73","year":"1995","unstructured":"Fritz, D. L., N. K. Jaax, W. B. Lawrence, K. J. Davis, M. L. M. Pitt, J. W. Ezzell, and A. M. Friedlander. 1995. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab. Investig.73:691-702.","journal-title":"Lab. Investig."},{"key":"e_1_3_2_22_2","first-page":"416","volume":"44","year":"1963","unstructured":"Gleiser, C. A., C. C. Berdjis, H. A. Hartman, and W. S. Gochenour. 1963. Pathology of experimental respiratory anthrax in Macaca mulatta. Br. J. Exp. Pathol.44:416-426.","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1955.00250140109012"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2003.07.001"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.17.2236"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.2.303-308.1990"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)62213-6"},{"key":"e_1_3_2_28_2","first-page":"95","volume":"68","year":"1990","unstructured":"Lightfoot, N. F., R. J. D. Scott, and P. C. B. Turnbull. 1990. Antimicrobial susceptibility of Bacillus anthracis. Salisbury Med. Bull.68(Suppl.):95-98.","journal-title":"Salisbury Med. Bull."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.8.4801-4809.2004"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.6.2040-2042.2003"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8502(73)90006-2"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.1902-1907.2002"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1258\/002367795780740393"},{"key":"e_1_3_2_34_2","unstructured":"National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press Washington DC."},{"key":"e_1_3_2_35_2","unstructured":"NCCLS\/CLSI. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 7th ed. vol. 23 no. 2. Approved standard M7-A7. NCCLS\/CLSI Wayne PA."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.5.429"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.7.2362-2365.2003"},{"key":"e_1_3_2_38_2","first-page":"30","year":"1982","unstructured":"Russell, A. D. 1982. The destruction of bacterial spores, p. 30-77. Academic Press, New York, NY.","journal-title":"The destruction of bacterial spores"},{"key":"e_1_3_2_39_2","unstructured":"U.S. Food and Drug Administration. 2002. Draft guidance for industry inhalational anthrax (post-exposure)\u2014development of antimicrobial drugs. CDER U.S. Food and Drug Administration Washington DC."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.51.3.795-800.1986"},{"key":"e_1_3_2_41_2","first-page":"982","volume":"122","year":"1998","unstructured":"Zaucha, G. M., L. M. Pitt, J. Estep, B. E. Ivins, and A. M. Friedlander. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med.122:982-992.","journal-title":"Arch. Pathol. Lab. Med."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01050-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01050-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:18:25Z","timestamp":1645471105000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01050-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1128\/AAC.01050-06"],"URL":"https:\/\/doi.org\/10.1128\/aac.01050-06","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"2006-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-01-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}